1. Home
  2. CLM vs BHVN Comparison

CLM vs BHVN Comparison

Compare CLM & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cornerstone Strategic Value Fund Inc. New

CLM

Cornerstone Strategic Value Fund Inc. New

HOLD

Current Price

$7.31

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$13.79

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLM
BHVN
Founded
N/A
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.2B
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
CLM
BHVN
Price
$7.31
$13.79
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$29.08
AVG Volume (30 Days)
1.5M
2.3M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.92
$7.48
52 Week High
$8.53
$18.57

Technical Indicators

Market Signals
Indicator
CLM
BHVN
Relative Strength Index (RSI) 39.85 43.00
Support Level $7.05 $8.25
Resistance Level $7.70 $14.01
Average True Range (ATR) 0.11 0.87
MACD -0.02 -0.35
Stochastic Oscillator 29.09 5.08

Price Performance

Historical Comparison
CLM
BHVN

About CLM Cornerstone Strategic Value Fund Inc. New

Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, Consumer Staples, utilities, energy, Real Estate, materials, and other sectors.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: